BIO-RAD LABORATORIES, INC. (BIO)

SEC filing

BIO-RAD LABORATORIES, INC.

BIO-B · CIK 12208

4 · Sep 9, 2026 · EVP, GBL Commercial Operations Mehta Rajat exercised options for 1,826 shares; reported 737 shares

EVP, GBL Commercial Operations Mehta Rajat exercised options for 1,826 shares; reported 737 shares

FORM 4

xslF345X06/wk-form4_1788993866.xmlSEC.gov

Graphics and non-inline formats (not embedded below).